A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
Clinical trial NCT02173301 · COMPLETED
Trial details
- NCT number
- NCT02173301
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.